Allurion Technologies Inc. (ALUR)

NYSE: ALUR · IEX Real-Time Price · USD
1.750
-0.010 (-0.57%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

The company is headquartered in Natick, Massachusetts.

Allurion Technologies Inc.
Allurion Technologies logo
Country United States
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 268
CEO Dr. Shantanu K. Gaur M.D.

Contact Details

Address:
11 Huron Dr Ste 200
Natick, Massachusetts 01760
United States
Phone 508-647-4000
Website allurion.com

Stock Details

Ticker Symbol ALUR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001964979
ISIN Number US02008G1022
SIC Code 3841

Key Executives

Name Position
Dr. Shantanu K. Gaur M.D. Co-Founder, Chief Executive Officer, President and Director
Dr. Samuel G. Levy Co-Founder
Christopher Geberth Chief Financial Officer and Treasurer
Dr. Ram Chuttani M.D. MD, Chief Medical Officer and Founding Partner
Brendan Michael Gibbons Chief Legal Officer and Corporate Secretary
Matt Wright Vice President of People
Joyce Johnson Senior Vice President of RA and QA

Latest SEC Filings

Date Type Title
Mar 26, 2024 10-K Annual Report
Mar 21, 2024 424B3 Prospectus
Mar 21, 2024 424B3 Prospectus
Mar 21, 2024 8-K Current Report
Mar 15, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 8, 2024 8-K Current Report
Jan 2, 2024 424B3 Prospectus
Jan 2, 2024 424B3 Prospectus
Dec 29, 2023 EFFECT Notice of Effectiveness